Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Read More
Search Results for: lung cancer
New Systems Biology Approach Improves Cancer Diagnosis Using Multi-Omic Data
Researchers at Yeditepe University have developed a machine learning classifier that integrates multi-omic data and metabolic modeling, improving lung and pancreatic cancer diagnosis accuracy, according to a study in Quantitative Biology.
Read More
Illumina Secures CMS Reimbursement for TruSight Oncology Test
Illumina’s FDA-approved TruSight Oncology test will be reimbursed by CMS at $2,989.55 per test starting Jan. 1, 2026, enabling broader laboratory access to genomic profiling for Medicare beneficiaries.
Read More
Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance
The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.
Read More
First Ascent Biomedical Opens Cancer Testing Lab in Miami
The CLIA-certified facility offers functional precision medicine testing that analyzes live tumor cells against FDA-approved therapies within 10 days.
Read More